Who? Soomro et al. - better outcomes for SSRIs compared to placebos - symptoms reduce around 70%
Why? Drugs most helpful
Counterpoint: Evidence of effectiveness
What? Not most effective treatment
Who? Skapinakis et al. - cognitive/behaviouraltherapiesmore effective
Why? Not optimum treatment
Strength: Cost-effective and non-disruptive
What? Cost-effective and non-disruptive
Who? Good value for the NHS as they're cheap and they're non-disruptive to people's lives
Why? Popular with people with OCD and doctors
Limitation: Serious side-effects
What? Potentially seriousside-effects
Who? Side-effects: indigestion, blurred vision, loss of sex drive - usually temporary but can be distressing - those taking clomipramine have more seriousside effects: weight gain, aggression, erection problems, heart-related problems
